Market Pulse: Yesterday, developments in medical robotics stole the show, fueled by GlobeNewswire’s “Medical Robot Market Size to Worth USD 39.07 Billion by 2034” study pointing to booming minimally invasive procedures. Meanwhile, whispers from Forbes’s “Nvidia Expands Into Quantum Computing And Fusion Power” hint at a chipmaker eyeing new frontiers.
Key Movers: Small-cap robotics developers and tooling providers climbed into focus after Statifacts-backed research on the medical robot surge, and Nvidia grabbed headlines with fusion and quantum aspirations in Forbes’s coverage.
Macro & Politics: Regulators in Washington and Brussels are circling gene editing and AI frameworks, as MIT Technology Review warns in “Here’s the latest company planning for gene-edited babies” that policy shifts could reshape biotech.
What’s Next: Watch Cellectis’s Q3 preview on Nov. 7 and heed the mixed options sentiment swirling around Richtech Robotics ahead of their earnings cadence.
📈 Breaking Financial News
Chinese Unleashing AI-Powered Robot Dinosaurs
AI-powered dinosaurs are coming, pumped out by robotics companies looking to shave off a piece of the edu-tainment market.
NOVARC REVEALS THE WORLD’S FIRST FULLY AUTONOMOUS TIG WELDING SOLUTION BUILT IN BRITISH COLUMBIA
Breakthrough innovation strengthens B.C.’s position as a global leader in advanced manufacturing and AI VANCOUVER, CANADA, Oct. 31, 2025 (GLOBE NEWSWIRE) — Novarc Technologies Inc., a full-stack AI robotics company pioneering automated welding solutions.
Mixed options sentiment in Richtech Robotics Inc with shares down 5.05%
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corporates informed.
Medical Robot Market Size to Worth USD 39.07 Billion by 2034 Rising Demand for Minimally Invasive Surgeries Drives Medical Robot Adoption
The global medical robot market size will soar from USD 13.01 billion in 2025 and is estimated to hit around USD 39.07 billion by 2034, registering a CAGR of 13% from 2025 to 2034. A study published by Statifacts, a sister firm of Precedence Research.
Humanoid Global Announces Advertising Agreements
Vancouver, BC, Oct. 31, 2025 (GLOBE NEWSWIRE) — Humanoid Global Holdings Corp. (CSE:ROBO, FWB:0XM1, OTCQB:RBOHF), a publicly traded investment issuer focused on building and accelerating a portfolio of pioneering companies.
30 Million Ounces of Gold Just Moved to the U.S.
And It's Not a Coincidence… A historic gold transfer is underway – and according to 20-year gold analyst Garrett Goggin, it's a clear signal the global monetary system is about to change. Central Banks are already buying at record pace. But Goggin says four tiny miners are positioned for the biggest upside – with 100X potential as this “Golden Anomaly” unfolds. Click here to get all four picks before the window closes.
🔍 Market Analysis & Insights
Humanoid Global Announces Advertising Agreements
Vancouver, BC, Oct. 31, 2025 (GLOBE NEWSWIRE) — Humanoid Global Holdings Corp. (“Humanoid Global” or the “Company”) (CSE:ROBO, FWB:0XM1, OTCQB:RBOHF), a publicly traded investment issuer focused on building and accelerating a portfolio of pioneering ventures.
Why These Five Photography Jobs Are (Mostly) Safe From AI
While artificial intelligence rapidly consumes entire segments of the photography industry, there's a silver lining that deserves attention. Certain specializations possess qualities that make them remarkably resistant to replacement by AI systems.
Cellectis to Report Third Quarter Financial Results on November 7, 2025
NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced the date for its Q3 financial results.
Here’s the latest company planning for gene-edited babies
A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the taboo technology.
Inside Cisco and Nvidia’s new N9100 switch and WWT’s role in scaling AI infrastructure
Cisco Systems Inc. and Nvidia Corp. recently unveiled a co-developed AI infrastructure solution: the Cisco N9100 switch. The hardware symbolizes a new phase in the race to deliver scalable, high-performance AI systems, with WWT driving global deployment.
Oil Jumps 8.5% on Middle East Crisis
Oil surged 8.5% to $74/barrel after Israel' Experts predict $100+ oil if conflict spreads. Don't chase volatile oil stocks. See Marc's safer alternative here.
💰 Investment Opportunities
NOVARC REVEALS THE WORLD’S FIRST FULLY AUTONOMOUS TIG WELDING SOLUTION BUILT IN BRITISH COLUMBIA
Breakthrough innovation strengthens B.C.’s position as a global leader in advanced manufacturing and AI. This autonomous TIG-welding solution delivers consistency, cuts labor errors, and tightens margins for industrial players.
Three billionaires dropped by a fried-chicken joint—and Jensen Huang bought everyone dinner
Nvidia’s Jensen Huang sparked a Korean-fried-chicken stock surge after a viral dinner in Seoul.
Nvidia Expands Into Quantum Computing And Fusion Power
In this week’s edition of The Prototype, we look at why AI models struggle with finance, a revolutionary superconducting discovery, Pac-Man and more.
Is Nvidia’s AI Factory Leading To Reindustrialization?
From OpenAI's Stargate to Nvidia's AI Factory, we are witnessing a new form of industrialization centered on the mass production of intelligence.
The Cross-Chain Giant Set for 1,000%+ Gains As crypto markets surge post-tariffs
Its transaction volume is skyrocketing across all major blockchains while its price remains suppressed as retail has yet to discover it – creating a coiled spring ready to release. Breaking: Access our urgent research on this cross-chain opportunity for just $3!
Unfiltered Market Commentary
What everyone’s missing is how quickly regulators could clamp down on the robotics gold rush. Futurism’s “Chinese Unleashing AI-Powered Robot Dinosaurs” story shows Beijing’s appetite for hyper-realistic machines—and if state propaganda wings get tied to medical toolmakers, expect compliance costs to skyrocket. That’s a fast way to deflate small-cap excitement.
Pairing Forbes’s “Nvidia Expands Into Quantum Computing And Fusion Power” with MIT Technology Review’s “Here’s the latest company planning for gene-edited babies” reveals a broader thesis: tech titans and biotech rebels both chase foundational breakthroughs, but one misstep in policy or PR could torch valuations. It’s capitalism dancing with Frankenstein science.
Action time: overweight tooling names in robotics that dodge geopolitical entanglements, hedge gene-editing plays with protective options, and keep an eye on Nvidia’s fusion patents—because if lawmakers clamp one frontier, the other might sprint ahead. Stay nimble.